-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Arrowhead Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2017 to Q4 2023.
- Arrowhead Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was $267K, a 99.9% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $871M, a 244% increase from 2023.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $253M, a 288% increase from 2022.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $65.2M, a 477% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)